Renal Cancer - Results from #4500

Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG) April 19, 2018

Treatment of spinal metastases in renal cell carcinoma: A critical review April 18, 2018

Is routine use of renal tumor biopsy associated with lower rates of benign histology following nephrectomy for small renal masses? April 18, 2018

Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence April 17, 2018

Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal-Cell Carcinoma April 17, 2018

Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma April 16, 2018

Humeral metastasis of renal cancer: surgical options and a review of literature April 16, 2018

Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer April 13, 2018

Immune Checkpoint Blockade Therapy April 13, 2018

Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids April 12, 2018

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome April 12, 2018

Identifying and managing the adverse effects of immune checkpoint blockade April 12, 2018

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial April 10, 2018

Epidemiology and screening for renal cancer April 10, 2018

Incidence and Time of Onset of Osseous Pseudoprogression in Patients With Metastatic Spine Disease From Renal Cell or Prostate Carcinoma After Treatment With Stereotactic Body Radiation Therapy April 9, 2018

New-onset insulin-dependent diabetes due to nivolumab April 9, 2018

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer April 9, 2018

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma April 9, 2018

Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract April 6, 2018

Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma April 6, 2018

Page 226 of 456